HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeong Gwan Cho Selected Research

No-Reflow Phenomenon

7/2016Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction.
7/2013Impact of tissue prolapse after stent implantation on short- and long-term clinical outcomes in patients with acute myocardial infarction: an intravascular ultrasound analysis.
1/2013Comparison of triple anti-platelet therapy and dual anti-platelet therapy in patients with acute myocardial infarction who had no-reflow phenomenon during percutaneous coronary intervention.
8/2011Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis.
8/2009Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
8/2007Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
10/2004Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeong Gwan Cho Research Topics

Disease

71Myocardial Infarction
06/2021 - 03/2003
36Cardiovascular Diseases (Cardiovascular Disease)
09/2019 - 09/2003
22ST Elevation Myocardial Infarction
09/2019 - 08/2007
20Thrombosis (Thrombus)
11/2019 - 10/2004
17Death (Near-Death Experience)
09/2019 - 09/2003
17Hyperplasia
09/2011 - 07/2003
15Heart Failure
07/2017 - 10/2004
14Infarction (Infarctions)
01/2017 - 08/2007
12Coronary Artery Disease (Coronary Atherosclerosis)
12/2011 - 12/2004
11Pathologic Constriction (Stenosis)
01/2021 - 12/2003
9Acute Coronary Syndrome
01/2021 - 09/2003
9Diabetes Mellitus
01/2021 - 09/2003
8Coronary Restenosis
03/2015 - 12/2004
8Prolapse
10/2013 - 07/2008
7Atrial Fibrillation
01/2021 - 08/2013
7Left Ventricular Dysfunction
08/2019 - 10/2006
7No-Reflow Phenomenon
07/2016 - 10/2004
7Inflammation (Inflammations)
03/2015 - 06/2007
6Hemorrhage
01/2019 - 09/2003
5Non-ST Elevated Myocardial Infarction
11/2019 - 11/2008
5Neointima
03/2015 - 10/2007
5Hypertension (High Blood Pressure)
01/2015 - 01/2009
5Rupture
07/2010 - 07/2008
4Pulmonary Embolism
11/2019 - 01/2011
3Heart Arrest (Cardiac Arrest)
06/2021 - 07/2014
3Cardiogenic Shock
06/2021 - 02/2005
3Neoplasms (Cancer)
07/2020 - 06/2014
3Breast Neoplasms (Breast Cancer)
07/2020 - 12/2016
3Chronic Renal Insufficiency
12/2015 - 07/2014
3Angina Pectoris
01/2015 - 04/2009
3Reperfusion Injury
11/2012 - 01/2010
3Ischemia
11/2012 - 06/2010
3Unstable Angina
10/2010 - 09/2003
2Coronary Stenosis (Coronary Artery Stenosis)
01/2021 - 01/2011
2Thromboembolism
01/2019 - 12/2017
2Stroke (Strokes)
09/2018 - 07/2017
2Cardiac Arrhythmias (Arrythmia)
12/2017 - 09/2011
2Ventricular Remodeling
01/2017 - 06/2009
2Spasm (Spasms)
01/2016 - 10/2010
2Aneurysm (Aneurysms)
08/2014 - 05/2011
2Fibrosis (Cirrhosis)
10/2013 - 06/2010
2Hypoxia (Hypoxemia)
11/2012 - 01/2012
2Atherosclerotic Plaque (Atheroma)
05/2012 - 09/2010
2Stable Angina
04/2012 - 04/2009

Drug/Important Bio-Agent (IBA)

31omega-Chloroacetophenone (Mace)IBA
05/2019 - 09/2003
13Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2019 - 12/2005
12C-Reactive ProteinIBA
01/2022 - 03/2003
9Abciximab (ReoPro)FDA Link
05/2011 - 10/2004
8Brain Natriuretic Peptide (Natrecor)FDA Link
07/2015 - 12/2005
6LDL CholesterolIBA
01/2015 - 11/2010
6Phenobarbital (Luminal)FDA Link
08/2014 - 09/2003
5Warfarin (Coumadin)FDA LinkGeneric
02/2020 - 10/2015
5CreatinineIBA
12/2015 - 04/2010
5Simvastatin (Zocor)FDA LinkGeneric
03/2015 - 03/2005
4Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2011
4salicylhydroxamic acid (SHAM)IBA
01/2020 - 05/2011
4pro-brain natriuretic peptide (1-76)IBA
07/2015 - 12/2005
4Rosuvastatin Calcium (Crestor)FDA Link
01/2015 - 06/2007
4MetalsIBA
12/2014 - 12/2010
4CalciumIBA
08/2011 - 07/2010
3Cilostazol (Pletal)FDA LinkGeneric
09/2020 - 05/2009
3Trastuzumab (Herceptin)FDA Link
07/2020 - 12/2016
3Angiotensin Receptor AntagonistsIBA
01/2015 - 04/2013
3oxidized low density lipoproteinIBA
01/2015 - 01/2011
3HDL CholesterolIBA
07/2014 - 04/2012
3Connexin 43 (Connexin43)IBA
10/2013 - 06/2010
3EnzymesIBA
04/2012 - 12/2005
3Heparin (Liquaemin)FDA LinkGeneric
06/2011 - 09/2003
3Carvedilol (Coreg)FDA LinkGeneric
03/2011 - 01/2005
3Sirolimus (Rapamycin)FDA Link
01/2011 - 06/2007
3Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2010 - 09/2003
3Indicators and Reagents (Reagents)IBA
12/2009 - 03/2005
2RivaroxabanIBA
01/2021 - 01/2019
2TroponinIBA
11/2019 - 12/2013
2Troponin IIBA
11/2019 - 12/2005
2Glucose (Dextrose)FDA LinkGeneric
09/2019 - 07/2014
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018 - 06/2006
2Paclitaxel (Taxol)FDA LinkGeneric
12/2016 - 01/2011
2FibrinIBA
03/2015 - 06/2006
2Ezetimibe (Zetia)FDA Link
03/2015 - 05/2010
2Glycoproteins (Glycoprotein)IBA
04/2014 - 11/2010
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2014 - 09/2013
2Losartan (Cozaar)FDA LinkGeneric
10/2013 - 04/2013
2Coloring Agents (Dyes)IBA
10/2013 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2012 - 01/2009
2Hemoglobins (Hemoglobin)IBA
04/2012 - 03/2011
2LipidsIBA
04/2012 - 07/2010
2Oxytocin (Pitocin)FDA LinkGeneric
01/2012 - 06/2010
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2011 - 04/2009
2zotarolimusIBA
01/2011 - 03/2010

Therapy/Procedure

53Percutaneous Coronary Intervention
06/2021 - 03/2003
45Stents
09/2019 - 07/2003
23Therapeutics
07/2020 - 09/2003
11Drug-Eluting Stents
03/2015 - 10/2007
9Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2015 - 05/2003
2Drug Therapy (Chemotherapy)
07/2020 - 12/2016
2Aftercare (After-Treatment)
09/2019 - 09/2015
2Patient Readmission
01/2018 - 09/2015
2Secondary Prevention
08/2015 - 01/2015
2Dual Anti-Platelet Therapy
02/2014 - 01/2013